Oezel, Lisa
Memtsoudis, Stavros G.
Moser, Manuel
Zhong, Haoyan
Adl Amini, Dominik
Liu, Jiabin
Poeran, Jashvant
Shue, Jennifer
Sama, Andrew A. http://orcid.org/0000-0002-3014-7287
Article History
Received: 9 June 2022
Revised: 13 October 2022
Accepted: 11 November 2022
First Online: 21 December 2022
Declarations
:
: SGM is a one-time consultant for Teikoku. He is owner of a US Patent for a Multicatheter Infusion System. US-2017-0361063. He is the owner of SGM Consulting, LLC and co-owner of FC Monmouth, LLC. None of the above relations influenced the conduct of the present study. AAS has following healthcare industry relationships: Clariance, Inc.—Consultant; Scientific Advisory Board, Centinel Spine (Vbros Venture Partners V)—Ownership Interest, Depuy Synthes Products, Inc. (a Johnson & Johnson Company)—Advisory Board; Consultant; ISPH II, LLC -Ownership Interest, Kuros Biosciences- Consultant; Strategic Advisory Board, Medical Device Business Services, Inc (f/d/b/a DePuy Synthese, Inc.)- Advisory Board; Consultant; Designer, Ortho Development Corp.—Consultant; Designer; Royalties, Vestia Ventures MiRus Investment, LLC- Ownership Interest. All other authors declare no competing interest.
: This study was approved by the hospital’s Institutional Review Board (IRB #2012-050), and written informed consent was waived given the de-identified nature of the data.